<Term id="CDR0000037779" LegacyPDQID="10135" NCIThesaurusConceptID="C2237"><PreferredName>rV-B7.1 vaccine</PreferredName><OtherName><OtherTermName>rV-B7.1</OtherTermName><OtherNameType>Abbreviation</OtherNameType></OtherName><OtherName><OtherTermName>Recombinant Vaccinia-B7.1 Vaccine</OtherTermName><OtherNameType>Synonym</OtherNameType></OtherName><OtherName><OtherTermName>Recombinant Vaccinia-B7.1</OtherTermName><OtherNameType>Synonym</OtherNameType></OtherName><OtherName><OtherTermName>rV-B7 (Recomb Vaccinia/B7)</OtherTermName><OtherNameType>Synonym</OtherNameType></OtherName><OtherName><OtherTermName>8397</OtherTermName><OtherNameType>IND code</OtherNameType></OtherName><OtherName><OtherTermName>8202</OtherTermName><OtherNameType>IND code</OtherNameType></OtherName><OtherName><OtherTermName>699018</OtherTermName><OtherNameType>NSC code</OtherNameType></OtherName><Definition><DefinitionText>A recombinant vaccinia virus encoding the T-cell co-stimulatory molecule B7-1. Co-administration of recombinant vaccinia-B7.1 and a tumor-associated antigen in a cancer vaccine may enhance tumor-associated antigen-specific T-cell responses. Check for <ExternalRef xref="http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=37779&amp;idtype=1">active clinical trials</ExternalRef> or <ExternalRef xref="http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=37779&amp;idtype=1&amp;closed=1">closed clinical trials</ExternalRef> using this agent. (<ExternalRef xref="http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;code=C2237">NCI Thesaurus</ExternalRef>)</DefinitionText><DefinitionType>Health professional</DefinitionType></Definition><SemanticType ref="CDR0000256166">Drug/agent</SemanticType></Term>